Anti-aging research heading from lab animals toward early human testing for vision-focused therapies; this piece unpacks scientific context, risks, and hopes.
Key Takeaways
- David Sinclair's lab launched the world's first FDA approved anti-aging clinical trial
- Therapy ER100 delivers three Yamanaka factors labeled OSK for cellular reprogramming
- Mouse studies reportedly restored partial vision after optic nerve injury and improved glaucoma outcomes